Bevacizumab in recurrent high-grade pediatric gliomas(†)

Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promise in treating recurrent adult high-grade glioma (HGG). However, there is very little data on recurrent or progressive pediatric HGG treated with bevacizumab. We report the results of a single institution e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Narayana, Ashwatha, Kunnakkat, Saroj, Chacko-Mathew, Jeena, Gardner, Sharon, Karajannis, Matthias, Raza, Shahzad, Wisoff, Jeffrey, Weiner, Howard, Harter, David, Allen, Jeffrey
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2010
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2940690/
https://ncbi.nlm.nih.gov/pubmed/20363768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noq033
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars